Updated on 2026/04/01

写真a

 
KATO Noritoshi
 
Organization
Nagoya University Hospital Nephrology Lecturer
Graduate School
Graduate School of Medicine
Title
Lecturer

Degree 1

  1. 博士(医学) ( 2009.7   名古屋大学 ) 

Research Interests 4

  1. microRNA

  2. 遺伝学的検査

  3. 遺伝子治療

  4. Polycystic kidney

Research Areas 2

  1. Life Science / Nephrology

  2. Life Science / Genetics

Professional Memberships 2

  1. 日本透析医学会

  2. 日本腎臓学会

 

Papers 73

  1. Generation of a human-induced pluripotent stem cell line (NUMNi003-A) from a patient with autosomal dominant polycystic kidney disease harboring a<i> PKD1</i> gene variant Open Access

    Tanaka, A; Furuhashi, K; Horinouchi, A; Fujieda, K; Matsumoto, J; Hattori, K; Onogi, C; Kawazoe, T; Kato, A; Watanabe, Y; Koshi-Ito, E; Kato, N; Kushima, I; Ozaki, N; Maruyama, S

    STEM CELL RESEARCH   Vol. 93   page: 103967   2026.6

  2. C3 mutation-associated atypical hemolytic uremic syndrome with severe renal dysfunction and hypertensive emergency successfully treated with ravulizumab and sacubitril/valsartan: a case report Open Access

    Yanagidani, H; Maeoka, Y; Yoshida, M; Ueda, M; Kumano, M; Takahashi, A; Okubo, A; Kato, N; Maruyama, S; Masaki, T

    BMC NEPHROLOGY   Vol. 27 ( 1 )   2026.2

  3. Kidney Transplantation After Rituximab Treatment for End-Stage Renal Failure With Myeloperoxidase Anti-neutrophil Cytoplasmic and Anti-glomerular Basement Membrane Antibody Positivity: A Case Report.

    Sugiura T, Tanaka A, Nishibori N, Ozeki T, Sato Y, Maeda K, Furuhashi K, Kato N, Kosugi T, Sano Y, Ishida S, Maruyama S

    Cureus   Vol. 17 ( 10 ) page: e94237   2025.10

     More details

    Language:English  

    DOI: 10.7759/cureus.94237

    PubMed

  4. Urinary presepsin can efficiently detect T-cell-mediated rejection in patients who have undergone kidney transplantation

    Kawazoe, T; Tanaka, A; Furuhashi, K; Hattori, K; Onogi, C; Owaki, A; Kato, A; Watanabe, Y; Koshi-Ito, E; Kato, N; Kosugi, T; Sano, Y; Ishida, S; Maruyama, S

    CLINICAL AND EXPERIMENTAL NEPHROLOGY   Vol. 29 ( 9 ) page: 1300 - 1305   2025.9

     More details

  5. Management of Atypical Haemolytic Uraemic Syndrome With Triggers: Diagnostic and Treatment Algorithms From an Asia-Pacific Perspective

    Kang, HG; Hsu, D; Kato, N; Kim, JS; Okumi, M; Tseng, MH; Tu, KH; Yap, DYH; Lim, WH

    NEPHROLOGY   Vol. 30 ( 9 ) page: e70116   2025.9

     More details

  6. Dysregulated Anaerobic Glycolysis in Podocytes is Relevant to the Progression of Focal Segmental Glomerulosclerosis Open Access

    Sugimura, M; Maeda, K; Shibata, K; Seko, H; Kozaki, Y; Hirayama, A; Soga, T; Ozeki, T; Sato, Y; Kato, N; Kosugi, T; Kadomatsu, K; Maruyama, S

    KIDNEY INTERNATIONAL REPORTS   Vol. 10 ( 9 ) page: 3239 - 3254   2025.9

  7. Atypical hemolytic uremic syndrome treated with anti-C5 antibody agent eculizumab, without genetic complement abnormalities

    Sato, Y; Kato, N; Asano, M; Shimizu, H; Tatematsu, Y; Shimamura, Y; Horinouchi, A; Maeda, K; Kato, S; Kosugi, T; Maruyama, S

    NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 87 ( 3 ) page: 573 - 581   2025.8

     More details

  8. Safety and efficacy of retreatment with immune checkpoint inhibitors after severe immune-related adverse events

    Mizuno, K; Ito, T; Sawada, T; Kobayashi, T; Iwama, S; Mori, S; Hase, T; Fukami, Y; Furusawa, K; Yura, Y; Morimoto, R; Sajiki, A; Ushida, H; Kato, N; Maruyama, S; Murohara, T; Katsuno, M; Ishii, M; Akiyama, M; Arima, H; Kawashima, H; Ando, Y

    ONCOLOGIST   Vol. 30 ( 6 )   2025.6

     More details

  9. Ameliorative Effect of an Anti-MicroRNA-21 Oligonucleotide on Animal and Human Models of Cystic Kidney Disease

    Noda, Y; Kato, N; Sato, F; Suzuki, Y; Tsubota, S; Kitai, H; Komatsu, S; Tanaka, A; Sato, Y; Maeda, K; Furuhashi, K; Ishimoto, T; Kosugi, T; Yamaguchi, T; Nagao, S; Kamiya, Y; Kadomatsu, K; Asanuma, H; Maruyama, S

    KIDNEY360   Vol. 6 ( 6 ) page: 900 - 913   2025.6

     More details

  10. MPO-ANCA-positive rapidly progressive glomerulonephritis after COVID-19 vaccination during treatment of plaque psoriasis with bimekizumab Open Access

    Sugiura, T; Doke, T; Tanaka, A; Sato, Y; Maeda, K; Furuhashi, K; Kato, N; Kosugi, T; Maruyama, S

    CEN CASE REPORTS   Vol. 14 ( 2 ) page: 194 - 199   2025.4

     More details

  11. In vivo efficacy and safety of systemically administered serinol nucleic acid-modified antisense oligonucleotides in mouse kidney

    Tsuboi, T; Hattori, K; Ishimoto, T; Imai, K; Doke, T; Hagita, J; Ariyoshi, J; Furuhashi, K; Kato, N; Ito, Y; Kamiya, Y; Asanuma, H; Maruyama, S

    MOLECULAR THERAPY NUCLEIC ACIDS   Vol. 36 ( 1 ) page: 102387   2025.3

     More details

  12. Unexpected Hypotension in a Female Patient with Fabry Disease: Switching from Agalsidase α to β after Long-term ERT Open Access

    Sugiura, T; Muto, R; Amano, T; Kamiya, F; Sato, Y; Maeda, K; Saito, S; Katsuno, T; Kato, N; Higashi, M; Numaguchi, A; Matsuda, N; Sugiura, K; Maruyama, S

    INTERNAL MEDICINE   Vol. 64 ( 15 ) page: 2369 - 2374   2025

  13. Urinary presepsin is a novel biomarker capable of directly assessing monocyte/macrophage infiltration in kidney diseases

    Niwa, S; Tanaka, A; Furuhashi, K; Hattori, K; Onogi, C; Sunohara, K; Owaki, A; Kato, A; Kawazoe, T; Watanabe, Y; Koshi-Ito, E; Kato, N; Kosugi, T; Maruyama, S

    SCIENTIFIC REPORTS   Vol. 14 ( 1 ) page: 30088   2024.12

     More details

  14. Eculizumab for adult patients with atypical haemolytic-uraemic syndrome: full dataset analysis of Japanese post-marketing surveillance Open Access

    Maruyama, S; Ikeda, Y; Kaname, S; Kato, N; Matsumoto, M; Ishikawa, Y; Shimono, A; Miyakawa, Y; Nangaku, M; Shibagaki, Y; Okada, H

    JOURNAL OF NEPHROLOGY   Vol. 37 ( 8 ) page: 2181 - 2190   2024.11

  15. Safety and Tolerability of Adipose-Derived Mesenchymal Stem Cell (ADR-001) Therapy for IgA Nephropathy

    Tanaka, A; Furuhashi, K; Fujieda, K; Horinouchi, A; Maeda, K; Saito, S; Mimura, T; Saka, Y; Naruse, T; Ishimoto, T; Kato, N; Kosugi, T; Kinoshita, F; Kuwatsuka, Y; Nakai, Y; Maruyama, S

    KIDNEY360   Vol. 5 ( 11 ) page: 1692 - 1705   2024.11

     More details

  16. Annual trends in atypical haemolytic uremic syndrome management in Japan and factors influencing early diagnosis and treatment: a retrospective study

    Tatematsu, Y; Imaizumi, T; Michihata, N; Kato, N; Kumazawa, R; Matsui, H; Fushimi, K; Yasunaga, H; Maruyama, S

    SCIENTIFIC REPORTS   Vol. 14 ( 1 ) page: 18265   2024.8

     More details

  17. Detecting and exploring kidney-derived extracellular vesicles in plasma

    Komatsu, S; Kato, N; Kitai, H; Funahashi, Y; Noda, Y; Tsubota, S; Tanaka, A; Sato, Y; Maeda, K; Saito, S; Furuhashi, K; Ishimoto, T; Kosugi, T; Maruyama, S; Kadomatsu, K

    CLINICAL AND EXPERIMENTAL NEPHROLOGY   Vol. 28 ( 7 ) page: 617 - 628   2024.7

     More details

  18. Association of calciprotein particles with serum phosphorus among patients undergoing conventional and extended-hours haemodialysis

    Nishibori, N; Okazaki, M; Miura, Y; Hishida, M; Kurasawa, S; Imaizumi, T; Kato, N; Kosugi, T; Kuro-o, M; Kasuga, H; Kaneda, F; Maruyama, S

    CLINICAL KIDNEY JOURNAL   Vol. 17 ( 6 ) page: sfae121   2024.6

     More details

  19. Clinical impact of proteinuria and hematuria remission criteria in IgA nephropathy patients defined by the Japanese Society of Nephrology

    Yasuda, Y; Kaihan, AB; Kaihan, AN; Tanaka, A; Imaizumi, T; Maeda, K; Kato, N; Kosugi, T; Maruyama, S

    NEPHROLOGY DIALYSIS TRANSPLANTATION   Vol. 39   2024.5

  20. Clinical impact of proteinuria and hematuria remission criteria in IgA nephropathy patients defined by the Japanese Society of Nephrology

    Yasuda, Y; Kaihan, AB; Kaihan, AN; Tanaka, A; Imaizumi, T; Maeda, K; Kato, N; Kosugi, T; Maruyama, S

    NEPHROLOGY DIALYSIS TRANSPLANTATION   Vol. 39   page: I736 - I737   2024.5

     More details

  21. Rationale and design of the Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study

    Kurasawa, S; Kato, S; Ozeki, T; Akiyama, S; Ishimoto, T; Mizuno, M; Tsuboi, N; Kato, N; Kosugi, T; Maruyama, S

    CLINICAL AND EXPERIMENTAL NEPHROLOGY   Vol. 28 ( 5 ) page: 431 - 439   2024.5

     More details

  22. Case report: A family of atypical hemolytic uremic syndrome involving a <i>CFH::CFHR1</i> fusion gene and <i>CFHR3-1-4-2</i> gene duplication Open Access

    Tasaki, Y; Tsujimoto, H; Yokoyama, T; Sugimoto, N; Kitajima, S; Fujii, H; Hidaka, Y; Kato, N; Maruyama, S; Inoue, N; Wada, T

    FRONTIERS IN IMMUNOLOGY   Vol. 15   page: 1360855   2024.3

  23. Clinical characteristics of anti-GBM disease with thrombotic microangiopathy: a case report and literature review Open Access

    Nakamura, Y; Kato, N; Tatematsu, Y; Arai, Y; Mori, N; Shibata, K; Yamazaki, M; Yasui, H; Fujiwara, S; Yamakawa, T; Maruyama, S

    CEN CASE REPORTS   Vol. 13 ( 1 ) page: 37 - 44   2024.2

     More details

  24. Overlapping Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy with Mutation in <i>CFI</i> in a Japanese Patient: A Case Report Open Access

    Osawa, K; Yamamoto, S; Yamano, Y; Kita, A; Okamoto, K; Kato, N; Tatematsu, Y; Kojima, F; Ohya, M; Hara, S; Murata, SI; Inoue, N; Maruyama, S; Araki, SI

    INTERNAL MEDICINE   Vol. 63 ( 12 ) page: 1777 - 1782   2024

  25. Basigin is released in extracellular vesicles derived from the renal tubular epithelium in response to albuminuria Open Access

    Watanabe, T; Maeda, K; Kato, N; Seko, H; Sugimura, M; Sato, Y; Ryuge, A; Kato, S; Kadomatsu, K; Maruyama, S; Kosugi, T

    NEPHROLOGY   Vol. 28 ( 11 ) page: 629 - 638   2023.11

     More details

  26. IgA-dominant glomerulonephritis with DNAJB9-negative fibrillar polytypic immunoglobulin deposits in the subepithelium Open Access

    Muto, R; Maeda, K; Fukui, S; Saito, S; Kato, N; Kosugi, T; Shimizu, A; Maruyama, S

    CEN CASE REPORTS   Vol. 12 ( 3 ) page: 323 - 328   2023.8

     More details

  27. Relapse of atypical hemolytic uremic syndrome triggered by COVID-19: a lesson for the clinical nephrologist Open Access

    Uwatoko, R; Shindo, M; Hashimoto, N; Iio, R; Ueda, Y; Tatematsu, Y; Kato, N; Maruyama, S; Hayashi, T

    JOURNAL OF NEPHROLOGY   Vol. 36 ( 5 ) page: 1439 - 1442   2023.6

     More details

  28. Application of a scoring system in Japanese patients diagnosed with atypical hemolytic uremic syndrome to assess the relationship between the score and clinical responses to eculizumab Open Access

    Wada, H; Teranishi, H; Shimono, A; Kato, N; Maruyama, S; Matsumoto, M

    THROMBOSIS JOURNAL   Vol. 21 ( 1 ) page: 43   2023.4

  29. Efficacy of On-line Hemodiafiltration for Rhabdomyolysis Presenting with Acute Kidney Injury Due to Unexpected Drug Abuse Open Access

    Sato, N; Inagaki, K; Takanashi, M; Muto, R; Kato, N; Maruyama, S; Akahori, T

    INTERNAL MEDICINE   Vol. 62 ( 19 ) page: 2865 - 2870   2023

  30. Systematic characterization of seed overlap microRNA cotargeting associated with lupus pathogenesis Open Access

    Kitai, H; Kato, N; Ogami, K; Komatsu, S; Watanabe, Y; Yoshino, S; Koshi, E; Tsubota, S; Funahashi, Y; Maeda, T; Furuhashi, K; Ishimoto, T; Kosugi, T; Maruyama, S; Kadomatsu, K; Suzuki, H

    BMC BIOLOGY   Vol. 20 ( 1 ) page: 248   2022.11

  31. Abnormal foreshortening of a Flow Re-Direction Endoluminal Device caused by in-stent thrombosis immediately after deployment br Open Access

    Otsuka, T; Izumi, T; Nishihori, M; Tsukada, T; Goto, S; Ikezawa, M; Kato, N; Nakano, M; Uda, K; Yokoyama, K; Araki, Y; Saito, R

    NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 84 ( 4 ) page: 884 - 889   2022.11

     More details

  32. Adrenomedullin for biologic-resistant Crohn's disease: A randomized, double-blind, placebo-controlled phase 2a clinical trial Open Access

    Kita, T; Ashizuka, S; Takeda, T; Matsumoto, T; Ohmiya, N; Nakase, H; Motoya, S; Ohi, H; Mitsuyama, K; Hisamatsu, T; Kanmura, S; Kato, N; Ishihara, S; Nakamura, M; Moriyama, T; Saruta, M; Nozaki, R; Yamamoto, S; Inatsu, H; Watanabe, K; Kitamura, K

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   Vol. 37 ( 11 ) page: 2051 - 2059   2022.11

     More details

  33. ECULIZUMAB FOR ADULT PATIENTS WITH ATYPICAL HAEMOLYTIC-UREMIC SYNDROME: FULL DATASET ANALYSIS OF POST-MARKETING SURVEILLANCE IN JAPAN

    Maruyama, S; Ikeda, Y; Kaname, S; Kato, N; Matsumoto, M; Ishikawa, Y; Shimono, A; Miyakawa, Y; Nangaku, M; Shibagaki, Y; Okada, H

    NEPHROLOGY DIALYSIS TRANSPLANTATION   Vol. 37   page: I231 - I232   2022.5

     More details

  34. A novel renal perivascular mesenchymal cell subset gives rise to fibroblasts distinct from classic myofibroblasts Open Access

    Minatoguchi, S; Saito, S; Furuhashi, K; Sawa, Y; Okazaki, M; Shimamura, Y; Kaihan, AB; Hashimoto, Y; Yasuda, Y; Hara, A; Mizutani, Y; Ando, R; Kato, N; Ishimoto, T; Tsuboi, N; Esaki, N; Matsuyama, M; Shiraki, Y; Kobayashi, H; Asai, N; Enomoto, A; Maruyama, S

    SCIENTIFIC REPORTS   Vol. 12 ( 1 ) page: 5389   2022.3

  35. The 30-year Natural History of Non-classic Fabry Disease with an R112H Mutation Open Access

    Muto, R; Inagaki, K; Kato, N; Maruyama, S; Akahori, T

    INTERNAL MEDICINE   Vol. 61 ( 11 ) page: 1727 - 1730   2022

  36. X-chromosome inactivation patterns in females with Fabry disease examined by both ultra-deep RNA sequencing and methylation-dependent assay Open Access

    Rossanti, R; Nozu, K; Fukunaga, A; Nagano, C; Horinouchi, T; Yamamura, T; Sakakibara, N; Minamikawa, S; Ishiko, S; Aoto, Y; Okada, E; Ninchoji, T; Kato, N; Maruyama, S; Kono, K; Nishi, S; Iijima, K; Fujii, H

    CLINICAL AND EXPERIMENTAL NEPHROLOGY   Vol. 25 ( 11 ) page: 1224 - 1230   2021.11

     More details

  37. Basigin deficiency prevents anaplerosis and ameliorates insulin resistance and hepatosteatosis Open Access

    Ryuge, A; Kosugi, T; Maeda, K; Banno, R; Gou, Y; Zaitsu, K; Ito, T; Sato, Y; Hirayama, A; Tsubota, S; Honda, T; Nakajima, K; Ozaki, T; Kondoh, K; Takahashi, K; Kato, N; Ishimoto, T; Soga, T; Nakagawa, T; Koike, T; Arima, H; Yuzawa, Y; Minokoshi, Y; Maruyama, S; Kadomatsu, K

    JCI INSIGHT   Vol. 6 ( 20 )   2021.10

  38. A Case of TAFRO Syndrome with Two Consecutive Renal Biopsies Following the Pathological Course of the Kidney

    Kato, N; Hasegawa, T; Muto, R; Tanaka, A; Sato, Y; Maeda, K; Furuhashi, K; Saito, S; Kosugi, T; Maruyama, S

    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY   Vol. 32 ( 10 ) page: 823 - 824   2021.10

     More details

  39. Eculizumab for Treatment of Recurrent Pregnancy-Triggered Atypical Hemolytic-Uremic Syndrome with a Mutation in Complement 3: A Case Report

    Miyabe, Y; Nakai, A; Watanabe, K; Karasawa, K; Kato, N; Maruyama, S; Moriyama, T; Nitta, K

    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY   Vol. 32 ( 10 ) page: 826 - 827   2021.10

     More details

  40. The ISN/RPS 2016 classification predicts renal prognosis in patients with first-onset class III/IV lupus nephritis Open Access

    Hachiya, A; Karasawa, M; Imaizumi, T; Kato, N; Katsuno, T; Ishimoto, T; Kosugi, T; Tsuboi, N; Maruyama, S

    SCIENTIFIC REPORTS   Vol. 11 ( 1 ) page: 1525   2021.1

  41. Acquired Fanconi Syndrome in a Patient with Nontyphoidal <i>Salmonella</i> Bacteremia Open Access

    Ryuge, A; Saito, S; Morioka, H; Hachiya, A; Kato, N; Ishimoto, T; Kosugi, T; Maruyama, S

    INTERNAL MEDICINE   Vol. 60 ( 5 ) page: 761 - 764   2021

  42. Refractory Hypotension Caused by Selenium Deficiency in a Patient on Peritoneal Dialysis Open Access

    Ryuge, A; Kim, H; Suzuki, Y; Okazaki, M; Kojima, H; Saito, S; Kato, N; Ishimoto, T; Kosugi, T; Maruyama, S; Mizuno, M

    INTERNAL MEDICINE   Vol. 60 ( 15 ) page: 2461 - 2464   2021

  43. THE ROLE OF FRUCTOSE METABOLISM IN VASCULAR ENDOTHELIAL FUNCTION IN DIABETES

    Ishimoto, T; Doke, T; Hayasaki, T; Kato, N; Maruyama, S

    NEPHROLOGY   Vol. 25   page: 62 - 62   2020.10

     More details

    Language:Japanese  

    Web of Science

  44. EXOSOMES FROM CKD PATIENTS HAVE ATHEROSCLEROGENIC PROPERTIES

    Kato, N; Nishio, F; Ishimoto, T; Kosugi, T; Maruyama, S

    NEPHROLOGY   Vol. 25   page: 62 - 62   2020.10

     More details

    Language:Japanese  

    Web of Science

  45. Endothelial-to-mesenchymal transition compromises vascular integrity to induce Myc-mediated metabolic reprogramming in kidney fibrosis. Open Access

    Lovisa S, Fletcher-Sananikone E, Sugimoto H, Hensel J, Lahiri S, Hertig A, Taduri G, Lawson E, Dewar R, Revuelta I, Kato N, Wu CJ, Bassett RL Jr, Putluri N, Zeisberg M, Zeisberg EM, LeBleu VS, Kalluri R

    Science signaling   Vol. 13 ( 635 )   2020.6

     More details

    Language:English  

    DOI: 10.1126/scisignal.aaz2597

    PubMed

  46. Ectopic Relapse of Anti-neutrophil Cytoplasmic Antibody-associated Pituitary Vasculitis with No Elevation of Anti-neutrophil Cytoplasmic Antibodies after Renal Remission Open Access

    Muto, R; Inagaki, K; Sato, N; Sameshima, T; Nagakura, Y; Baba, S; Kato, N; Maruyama, S; Akahori, T

    INTERNAL MEDICINE   Vol. 59 ( 24 ) page: 3187 - 3193   2020

  47. Fructose increases the activity of sodium hydrogen exchanger in renal proximal tubules that is dependent on ketohexokinase Open Access

    Hayasaki, T; Ishimoto, T; Doke, T; Hirayama, A; Soga, T; Furuhashi, K; Kato, N; Kosugi, T; Tsuboi, N; Lanaspa, MA; Johnson, RJ; Maruyama, S; Kadomatsu, K

    JOURNAL OF NUTRITIONAL BIOCHEMISTRY   Vol. 71   page: 54 - 62   2019.9

     More details

  48. miR-146a targeted to splenic macrophages prevents sepsis-induced multiple organ injury Open Access

    Funahashi, Y; Kato, N; Masuda, T; Nishio, F; Kitai, H; Ishimoto, T; Kosugi, T; Tsuboi, N; Matsuda, N; Maruyama, S; Kadomatsu, K

    LABORATORY INVESTIGATION   Vol. 99 ( 8 ) page: 1130 - 1142   2019.8

  49. CD147/Basigin Deficiency Prevents the Development of Podocyte Injury through FAK Signaling Open Access

    Yoshioka, T; Kosugi, T; Masuda, T; Watanabe, T; Ryuge, A; Nagaya, H; Maeda, K; Sato, Y; Katsuno, T; Kato, N; Ishimoto, T; Yuzawa, Y; Maruyama, S; Kadomatsu, K

    AMERICAN JOURNAL OF PATHOLOGY   Vol. 189 ( 7 ) page: 1338 - 1350   2019.7

     More details

  50. NOVEL PATHOPHYSIOLOGIC ROLE OF MIR-146A FOR SPLENIC MACROPHAGE INTERFERENCE IN SEPSIS-RELATED KIDNEY INJURY

    Funahashi, Y; Kato, N; Ishimoto, T; Kosugi, T; Maruyama, S

    NEPHROLOGY DIALYSIS TRANSPLANTATION   Vol. 34   2019.6

     More details

  51. Therapeutic efficacy of rituximab for the management of adult-onset steroid-dependent nephrotic syndrome: a retrospective study. Open Access

    Katsuno T, Masuda T, Saito S, Kato N, Ishimoto T, Kato S, Kosugi T, Tsuboi N, Kitamura H, Tsuzuki T, Ito Y, Maruyama S

    Clinical and experimental nephrology   Vol. 23 ( 2 ) page: 207 - 214   2019.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10157-018-1630-y

    Open Access

    Web of Science

    PubMed

  52. Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018 Open Access

    Okada Hirokazu, Yasuda Yoshinari, Kashihara Naoki, Asahi Koichi, Ito Takafumi, Kaname Shinya, Kanda Eiichiro, Kanno Yoshihiko, Shikata Kenichi, Shibagaki Yugo, Tsuchiya Ken, Tsuruya Kazuhiko, Nagata Daisuke, Narita Ichiei, Nangaku Masaomi, Hattori Motoshi, Hamano Takayuki, Fujimoto Shouichi, Moriyama Toshiki, Yamagata Kunihiro, Yamamoto Ryohei, Wakasugi Minako, Ashida Akira, Usui Joichi, Kawamura Kazuko, Kitamura Kenichiro, Konta Tsuneo, Suzuki Yusuke, Tsuruoka Shuichi, Nishio Saori, Hamano Takayuki, Fujii Naohiko, Fujii Hideki, Wada Takehiko, Yokoyama Hitoshi, Aoki Katsunori, Akiyama Daiichiro, Araki Shin-ichi, Arima Hisatomi, Ishikawa Eiji, Ishikura Kenji, Ishizuka Kiyonobu, Ishimoto Takuji, Ishimoto Yu, Iseki Kunitoshi, Itabashi Mitsuyo, Ichioka Satoko, Ichikawa Kazunobu, Ichikawa Daisuke, Inoue Shuji, Imai Toshimi, Imamura Hideaki, Iwata Yasunori, Iwazu Yoshitaka, Usui Toshiaki, Uchida Keiko, Egawa Masahiro, Ohara Shinichiro, Omori Norio, Okada Rieko, Okuda Yusuke, Ozeki Takaya, Obata Yoko, Kai Hirayasu, Kato Noritoshi, Kanasaki Keizo, Kaneko Yoshikatsu, Kabasawa Hideyuki, Kawaguchi Takehiko, Kawasaki Yukihiko, Kawashima Keisuke, Kawano Haruna, Kikuchi Kan, Kihara Masao, Kimura Yoshiki, Kurita Noriaki, Koike Kentaro, Koizumi Masahiro, Kojima Chiari, Goto Shunsuke, Konomoto Takao, Kohagura Kentaro, Komatsu Hiroyuki, Komaba Hirotaka, Saito Chie, Sakai Yukinao, Sakaguchi Yusuke, Satonaka Hiroshi, Jimi Kanako, Shimizu Akihiro, Shimizu Sayaka, Shirai Sayuri, Shinzawa Maki, Sugiyama Kazuhiro, Suzuki Tomo, Suzuki Hitoshi, Suyama Kazuhide, Segawa Hiroyoshi, Takahashi Kazuya, Tanaka Kenichi, Tanaka Tetsuhiro, Tsunoda Ryoya, Tsuruta Yuki, Nakakura Hyogo, Nagasawa Yasuyuki, Nakanishi Koichi, Nagahama Masahiko, Nakaya Izaya, Nanami Masayoshi, Niihata Kakuya, Nishi Shinichi, Nishiwaki Hiroki, Hasegawa Shoko, Hasegawa Midori, Hanada Ken, Hayashi Hiroki, Harada Ryoko, Hishida Manabu, Hirano Daishi, Hirahashi Junichi, Hirama Akio, Hirayama Kouichi, Fukagawa Masafumi, Fukuda Akihiro, Fujii Yoshiyuki, Fujisaki Kiichiro, Furuya Fumihiko, Hoshino Junichi, Hosojima Michihiro, Honda Kenjiro, Masuda Takahiro, Matsui Kosuke, Matsukuma Yuta, Matsumura Hideki, Mii Akiko, Miura Kenichiro, Mitobe Michihiro, Miyasato Yoshikazu, Miyamoto Satoshi, Miwa Saori, Yazawa Masahiko, Yata Yusuke, Yamamoto Yoshihiro, Watanabe Kimio, Hosojima Michihiro

    CLINICAL AND EXPERIMENTAL NEPHROLOGY   Vol. 23 ( 1 ) page: 1-15   2019.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10157-018-1648-1

    Web of Science

  53. Investigation on the benefits of mycophenolate mofetil and therapeutic drug monitoring in the treatment of Japanese patients with lupus nephritis. Open Access

    Katsuno T, Ozaki T, Ozeki T, Hachiya A, Kim H, Kato N, Ishimoto T, Kato S, Kosugi T, Tsuboi N, Mizuno M, Ito Y, Maruyama S

    Clinical and experimental nephrology   Vol. 22 ( 6 ) page: 1341 - 1350   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10157-018-1590-2

    Open Access

    Web of Science

    PubMed

  54. Lacking ketohexokinase-A exacerbates renal injury in streptozotocin-induced diabetic mice. Open Access

    Doke T, Ishimoto T, Hayasaki T, Ikeda S, Hasebe M, Hirayama A, Soga T, Kato N, Kosugi T, Tsuboi N, Lanaspa MA, Johnson RJ, Kadomatsu K, Maruyama S

    Metabolism: clinical and experimental   Vol. 85   page: 161 - 170   2018.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.metabol.2018.03.020

    Web of Science

    PubMed

  55. The clinical relevance of plasma CD147/basigin in biopsy-proven kidney diseases Open Access

    Mori Yoshiko, Masuda Tomohiro, Kosugi Tomoki, Yoshioka Tomoki, Hori Mayuko, Nagaya Hiroshi, Maeda Kayaho, Sato Yuka, Kojima Hiroshi, Kato Noritoshi, Ishimoto Takuji, Katsuno Takayuki, Yuzawa Yukio, Kadomatsu Kenji, Maruyama Shoichi

    CLINICAL AND EXPERIMENTAL NEPHROLOGY   Vol. 22 ( 4 ) page: 815 - 824   2018.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10157-017-1518-2

    Open Access

    Web of Science

    PubMed

  56. MIR-146A TARGETING SPLENIC MACROPHAGES PREVENTS SEPSIS-INDUCED MULTIPLE ORGAN INJURY INCLUDING ACUTE KIDNEY INJURY

    Funahashi Yoshio, Kato Noritoshi, Kitai Hiroki, Ishimoto Takuji, Kosugi Tomoki, Tsuboi Naotake, Matsuda Naoyuki, Maruyama Shoichi, Kadomatsu Kenji

    SHOCK   Vol. 49 ( 6 ) page: 21 - 21   2018.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  57. THE DURATION FROM THE RECOGNITION OF SHOCK TO THE INITIATION OF PMX-DHP IS A CRITICAL DETERMINANT OF SURVIVAL IN PATIENTS WITH SEPTIC SHOCK

    Funahashi Yoshio, Kato Noritoshi, Ozeki Takaya, Kobayashi Azusa, Oishi Hideto, Maruyama Shoichi

    SHOCK   Vol. 49 ( 6 ) page: 68 - 68   2018.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  58. INDUCTION OF IMMUNOSUPPRESSIVE MICRO-RNA IN SPLEEN ATTENUATES SEPSIS INDUCED ACUTE KIDNEY INJURY

    Funahashi, Y; Kato, N; Ishimoto, T; Kosugi, T; Tsuboi, N; Kadomatsu, K; Maruyama, S

    NEPHROLOGY DIALYSIS TRANSPLANTATION   Vol. 32   2017.5

     More details

  59. Growth Factor Midkine Promotes T-Cell Activation through Nuclear Factor of Activated T Cells Signaling and Th1 Cell Differentiation in Lupus Nephritis Open Access

    Masuda Tomohiro, Maeda Kayaho, Sato Waichi, Kosugi Tomoki, Sato Yuka, Kojima Hiroshi, Kato Noritoshi, Ishimoto Takuji, Tsuboi Naotake, Uchimura Kenji, Yuzawa Yukio, Maruyama Shoichi, Kadomatsu Kenji

    AMERICAN JOURNAL OF PATHOLOGY   Vol. 187 ( 4 ) page: 740 - 751   2017.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.ajpath.2016.12.006

    Web of Science

    PubMed

  60. A CASE OF RAPIDLY PROGRESSIVE NEPHRITIC SYNDROME AND NEPHROTIC SYNDROME DURING THE TREATMENT OF DERMATOMYOSITIS AND DIABETES

    Sato Naokazu, Katsuno Takayuki, Mori Masayoshi, Saito Shouji, Kato Noritoshi, Ishimoto Takuji, Kosugi Tomoki, Tsuboi Naotake, Ito Yasuhiko, Maruyama Shouichi

    RHEUMATOLOGY   Vol. 56   page: 75 - 75   2017.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  61. Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience Open Access

    Katsuno Takayuki, Ozaki Takenori, Kim Hangsoo, Kato Noritoshi, Suzuki Yasuhiro, Akiyama Shinichi, Ishimoto Takuji, Kosugi Tomoki, Tsuboi Naotake, Ito Yasuhiko, Maruyama Shoichi

    INTERNAL MEDICINE   Vol. 56 ( 13 ) page: 1679 - 1686   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.2169/internalmedicine.56.7908

    Open Access

    Web of Science

    PubMed

  62. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse. Reviewed Open Access

    J Rheumatol.     page: 1853-60   2015.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3899

  63. CD147/basigin limits lupus nephritis and Th17 cell differentiation in mice by inhibiting the interleukin-6/STAT-3 pathway. Reviewed

    Maeda K, Kosugi T, Sato W, Kojima H, Sato Y, Kamimura D, Kato N, Tsuboi N, Yuzawa Y, Matsuo S, Murakami M, Maruyama S, Kadomatsu K.

    Arthritis Rheumatol.     page: 2185-95   2015.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/art.39155.

  64. The efficacy of tolvaptan as a diuretic for chronic kidney disease patients. Reviewed

    Tanaka A, Katsuno T, Ozaki T, Sakata F, Kato N, Suzuki Y, Kosugi T, Kato S, Tsuboi N, Sato W, Yasuda Y, Mizuno M, Ito Y, Matsuo S, Maruyama S.

    Acta Cardiol.     page: 217-23.   2015.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.2143/AC.70.2.3073514

  65. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Reviewed Open Access

    Melo SA, Sugimoto H, O'Connell JT, Kato N, Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, Lucci A, Ivan C, Calin GA, Kalluri R

    Cancer Cell     page: 707-21   2014.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.ccell.2014.09.005

  66. CD147/basigin reflects renal dysfunction in patients with acute kidney injury. Reviewed

    Nagaya H, Kosugi T, Maeda-Hori M, Maeda K, Sato Y, Kojima H, Hayashi H, Kato N, Ishimoto T, Sato W, Yuzawa Y, Matsuo S, Kadomatsu K, Maruyama S.

    Clin Exp Nephrol.     page: 746-54   2014.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10157-013-0916-3

  67. TGF-β1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. Reviewed Open Access

    Borges FT, Melo SA, Özdemir BC, Kato N, Revuelta I, Miller CA, Gattone VH 2nd, LeBleu VS, Kalluri R.

    J Am Soc Nephrol.     page: 385-92.   2013.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1681/ASN.2012101031

  68. Deficiency of growth factor midkine exacerbates necrotizing glomerular injuries in progressive glomerulonephritis. Reviewed Open Access

    Kojima H, Kosugi T, Sato W, Sato Y, Maeda K, Kato N, Kato K, Inaba S, Ishimoto T, Tsuboi N, Matsuo S, Maruyama S, Yuzawa Y, Kadomatsu K.

    Am J Pathol.     page: 410-9   2013.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.ajpath.2012.10.016

  69. Basigin/CD147 promotes renal fibrosis after unilateral ureteral obstruction. Reviewed Open Access

    Kato N, Kosugi T, Sato W, Ishimoto T, Kojima H, Sato Y, Sakamoto K, Maruyama S, Yuzawa Y, Matsuo S, Kadomatsu K.

    Am J Pathol.     page: 572-9.   2011.2

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.ajpath.2010.10.009

    Open Access

  70. The E-selectin ligand basigin/CD147 is responsible for neutrophil recruitment in renal ischemia/reperfusion. Reviewed Open Access

    Kato N, Yuzawa Y, Kosugi T, Hobo A, Sato W, Miwa Y, Sakamoto K, Matsuo S, Kadomatsu K.

    J Am Soc Nephrol.     page: 1565-76   2009.7

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1681/ASN.2008090957

  71. The growth factor midkine regulates the renin-angiotensin system in mice. Reviewed Open Access

    Hobo A, Yuzawa Y, Kosugi T, Kato N, Asai N, Sato W, Maruyama S, Ito Y, Kobori H, Ikematsu S, Nishiyama A, Matsuo S, Kadomatsu K.

    J Clin Invest.     page: 1616-25   2009.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1172/JCI37249

  72. Overexpression of calmodulin in pancreatic beta cells induces diabetic nephropathy. Reviewed Open Access

    Yuzawa Y, Niki I, Kosugi T, Maruyama S, Yoshida F, Takeda M, Tagawa Y, Kaneko Y, Kimura T, Kato N, Yamamoto J, Sato W, Nakagawa T, Matsuo S.

    J Am Soc Nephrol.     page: 1701-11   2008.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1681/ASN.2006121358

  73. Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathy. Reviewed

    Kosugi T, Yuzawa Y, Sato W, Arata-Kawai H, Suzuki N, Kato N, Matsuo S, Kadomatsu K.

    Lab Invest.     page: 903-13   2007.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/labinvest.3700599

▼display all

MISC 1

  1. miR-146a targeted to splenic macrophages prevents sepsis-induced multiple organ injury Reviewed

    Funahashi Y, Kato N, Masuda T, Nishio F, Kitai H, Ishimoto T, Kosugi T, Tsuboi N, Matsuda N, Maruyama S, Kadomatsu K

    Laboratory investigation; a journal of technical methods and pathology     2019.1

     More details

    Language:English  

    DOI: 10.1038/s41374-019-0190-4

    PubMed

KAKENHI (Grants-in-Aid for Scientific Research) 12

  1. Development of cystic kidney disease and cystic liver disease treatment using anti-miRNA novel artificial nucleic acids

    Grant number:25K11520  2025.4 - 2028.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Principal investigator 

    Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )

  2. 新生児型Fc受容体を介した新規ループス腎炎進展機構の解明

    Grant number:25K11499  2025.4 - 2028.3

    科学研究費助成事業  基盤研究(C)

    前田 佳哉輔, 小杉 智規, 加藤 規利

      More details

    Authorship:Coinvestigator(s) 

    ループス腎炎は、全身性エリテマトーデスの重大な臓器障害の一つであり、強力な免疫抑制治療が推奨されるが、若年例が多いことから、ステロイド薬長期投与の副作用や、治療抵抗例が問題となる。そのため、新規標的薬の開発が望まれる。我々は、これまでにループス腎炎の標的となる糸球体上皮細胞(ポドサイト)の傷害について研究を進めており、本研究では、そのループス腎炎におけるポドサイト傷害機構の解明を目的とする。

  3. Functional Regulation and Therapeutic Applications of the CD147/Basigin Membrane Transport Complex responsible for Energy Homeostasis

    Grant number:24K11385  2024.4 - 2027.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Coinvestigator(s) 

  4. Development of Complement Function Tests for the Early Diagnosis of aHUS and Determination of Indications for Anti-complement Therapy

    Grant number:22K08349  2022.4 - 2025.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Kato Noritoshi

      More details

    Authorship:Principal investigator 

    Grant amount:\4160000 ( Direct Cost: \3200000 、 Indirect Cost:\960000 )

    Atypical hemolytic uremic syndrome (aHUS) is a form of thrombotic microangiopathy caused by activation of the alternative complement pathway. It is a life-threatening disease, primarily characterized by AKI as the organ involvement. In recent years, the advent of anti-C5 monoclonal antibody therapies has dramatically improved clinical outcomes. However, a definitive diagnosis still cannot be made based on direct assessment of complement activation, and treatment is typically initiated based on a diagnosis of exclusion.
    In this study, we developed two novel methods: (1) a liquid biopsy approach utilizing small extracellular vesicles (sEVs) to evaluate complement activation in vivo, and (2) a functional assay system to assess complement-activating potential in an ex vivo setting.These methods demonstrated excellent positive predictive value and are expected to enable treatment decisions based on positive findings, rather than relying on conventional exclusion-based diagnosis.

  5. Novel therapeutic targets for refractory nephrotic syndrome based on energy metabolism dynamics

    Grant number:22K08308  2022.4 - 2025.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Maeda Kayaho

      More details

    Authorship:Coinvestigator(s) 

    Focal segmental glomerulosclerosis (FSGS), a representative form of treatment-resistant nephrotic syndrome, is a heterogeneous disease. For the development of new treatments, it is desirable to identify subgroups that are less responsive to treatment and to elucidate the underlying pathophysiology. We identified a subgroup of patients with poorer treatment response by measuring the extent of damage to human podocyte cell lines exposed to patient serum. We found that energy production from glycolysis was reduced in this subgroup. This suggests that impaired glycolysis may be associated with FSGS progression and could serve as a new therapeutic target.

  6. Renal plasma flow (RPF) and accurate GFR equations utilizing metabolomics analysis

    Grant number:20H03575  2020.4 - 2023.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    Yasuda Yoshinari

      More details

    Authorship:Coinvestigator(s) 

    In this study, GFR and RPF were measured, and novel RPF equation was created by using metabolome analysis, which was validated in Japanese patients treated by SGLT2 inhibitor. Among patients with small muscle mass, new GFR equation using psoas muscle index (PMI) in CT images was created and validated in patients with spinal cord injury or spinal cord injury or anorexia nervosa. CKD-EPIcr 2021 equation without race coefficient has been reported, however we revealed that the equation overestimates GFR among Japanese patients and Japanese coefficient of 0.908 was needed. In international collaboration study measuring GFR by inulin clearance, we clarified that CKD-EPIcys2021 could accurately estimate GFR in Japanese and Indians, although they have smaller body muscle mass compared with Caucasians or African Americans.

  7. Usefulness of Basigin as a novel therapeutic target for diabetic kidney and liver diseases

    Grant number:20K08632  2020.4 - 2023.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    KOSUGI TOMOKI

      More details

    Authorship:Coinvestigator(s) 

    Basigin (Bsg) promotes intracellular transport of monocarboxylic acids. Upon high-fat diet loading, Bsg deficiency ameliorated diabetes and insulin resistance, and reduce renal damage and fatty liver disease. To develop new therapeutic strategies for diabetic kidney disease and fatty liver disease, this study aimed to elucidate the detailed involvements of Bsg in intracellular metabolic mechanisms and to conduct therapeutic experiments with artificial nucleic acids using high-fat diet-loaded mice. In primary cultured cells of liver and renal proximal tubules, intermediate metabolites in the TCA circuit were reduced by 30% to 70% by Bsg inhibition. Systemic administration experiments in high-fat diet-loaded mice showed a trend toward improvement in serological indices in the liver, but it was difficult to conclude that the treatment had a significant effect on diabetes mellitus.

  8. Development of a treatment for septic AKI using microRNAs and adipose stem cell-derived exosomes.

    Grant number:19K08676  2019.4 - 2022.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Noritoshi Kato

      More details

    Authorship:Principal investigator 

    Grant amount:\4420000 ( Direct Cost: \3400000 、 Indirect Cost:\1020000 )

    In our previous studies, we have succeeded in suppressing hypercytokinemia and improving survival in sepsis model mice by systemic administration of a plasmid expressing miR-146a, which was mainly taken up by the spleen.
    In this study, we focused on the spleen as a target for the treatment of sepsis and investigated the therapeutic effect of local injection into the spleen. We found that most of the nucleic acids after administration were taken up by the spleen, especially by splenic macrophages. While the therapeutic effect was protective against organ damage such as kidney and liver damage, this did not improve the survival rate. Therefore, the target disease and therapeutic miRNAs were changed, and the inhibitory effect on renal fibrosis caused by folic acid nephropathy was examined, and a certain inhibitory effect on fibrosis was confirmed.

  9. Novel CaMK4-mediated podocyte-specific therapy in refractory renal disease

    Grant number:19K08723  2019.4 - 2022.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Maeda Kayaho

      More details

    Authorship:Coinvestigator(s) 

    We elucidated the role of CaMK4 in refractory nephrotic syndrome such as focal segmental glomerulosclerosis, and developed podocyte-specific therapy. The findings using podocyte-specific CaMK4-deficient mice showed that CaMK4 in podocytes is involved in podocyte cell death and induces more proteinuria, and podocyte-directed nanoparticles with a CaMK4 inhibitor showed the efficacy compared to administration without nanoparticles.

  10. The development of nucleic acid therapeutic against sepsis targeting splenic macrophage

    Grant number:18K19562  2018.6 - 2020.3

    Grant-in-Aid for Challenging Research (Exploratory)

    Yasuda Yoshinari

      More details

    Authorship:Coinvestigator(s) 

    We have been involved in nucleic acid therapeutics using miR-146a expression vector for severe sepsis mice model. When introduced miR-146a expression vector with PEI, they are transfected into splenic macrophages and suppress cytokine storm and contribute to improve better survival. This time, we injected mature miR-146a directly into mice spleen. It improved organ damage but did not survival rate. In vitro study, we confirm our artificial nucleic acid suppress cytokine production. Now we are developing better therapeutic platform.

  11. Investigation of safer methods of therapeutic miRNA and exosomes

    Grant number:16K09610  2016.4 - 2019.3

    Kato Noritoshi

      More details

    Authorship:Principal investigator 

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    We investigated the pathophysiological role of exogenously applied microRNA (miRNA) in sepsis-induced multiple organ injury. In vitro, we tested possible miRNAs which suppressed the production of pro-inflammatory cytokines. Of these, miR-146a displayed the highest suppressive effect. Sepsis was induced in mice via cecal ligation and puncture (CLP) and an intravenous injection of a complex of miR-146a-expressing plasmid and polyethyleneimine. Treatment with this complex significantly decreased the level of serum inflammatory cytokines, attenuated organ injury, and led to increased survival from sepsis. miR-146a-expressing plasmid was abundantly distributed in splenic macrophages. CLP mice treated with miR-146a displayed significantly decreased NF-κB activation in the spleen. The collective results support the conclusion that the induction of miR-146a expression in splenic macrophages prevents excessive inflammation and sepsis-induced multiple organ injury.

  12. 心腎連関における細胞外小胞Exosomesの役割と、心予後予測因子の開発

    2014.4 - 2016.3

    科学研究費補助金  若手研究(B)

      More details

    Authorship:Principal investigator 

▼display all

Industrial property rights 1

  1. EXOSOMES RECOVERY METHOD FOR RENAL DISEASE DIAGNOSIS

    Noritoshi Kato

     More details

    Application no:特願2015-196263  Date applied:2015.10

    Announcement no:特開2017-067706  Date announced:2017.4

    Patent/Registration no:P160012741  Date registered:2017.4 

    Country of applicant:Domestic